DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Administration USFD.
FDA approved betrixaban (BEVYXXA, Portola) for the prophylaxis of venous thromboembolism (VTE) in adult patients.
June 23, 2007. Accessed September 2, 2020
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.